Joanna Strober, CEO and co-founder of Midi Health, said the company's virtual-care platform has helped 95 percent [1] of patients improve their symptoms.
The results highlight a growing movement to address the unmet healthcare needs of midlife women. By leveraging insurance-covered virtual care, the company aims to capture a significant portion of the menopause market.
Strober said the company's model during an interview on the program “The Close” on Tuesday. Midi Health focuses on perimenopause and menopause, providing specialized care through a digital interface. The company reports that patients typically see these improvements after at least two months of treatment [1].
The economic opportunity for specialized menopause care is substantial. Market analyses from June indicate the menopause market is estimated at $15 billion [2]. This valuation has attracted significant investment across the sector, including a $250 million capital race cited in some industry reports [5].
Competition in the space is intensifying. For example, Alloy Women’s Health, a competing menopause-care startup, has raised $21 million [4]. Despite the competition, Midi Health has reached a valuation of $1 billion [3].
Strober said the goal is to provide a scalable solution for women who have historically struggled to find specialized support for midlife hormonal transitions. The U.S.-based platform integrates with insurance to lower the barrier to entry for patients seeking hormone therapy or lifestyle management.
“95 percent of patients report symptom improvement after at least two months”
The rapid valuation growth of Midi Health and the emergence of competitors like Alloy Women’s Health signal a shift in how midlife women's health is commercialized. By moving menopause care into the virtual, insurance-covered space, these companies are attempting to formalize a sector of medicine that was previously fragmented or underserved, turning a public health gap into a high-growth investment vertical.
